Navigation Links
Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors

vely kills cisplatin-resistant cells when used as monotherapy, and restores cisplatin sensitivity. Cisplatin is one of the most commonly utilized treatments for lung, breast and colon cancers. However, development of cisplatin resistance is a common event and the ability of INGN 241 to kill these resistant tumors and restore cisplatin efficacy has important clinical implications. Previous INGN 241 preclinical studies have indicated similar synergies with other chemotherapies and with radiation treatment.

Dr. Chada added, "These preclinical data demonstrate that INGN 241 can restore sensitivity to cisplatin, a widely used chemotherapy drug that frequently gives rise to resistance. Our findings support applications of INGN 241 in combination with standard chemotherapy and radiation regimens and we are planning future clinical trials based on these results."

About INGN 241

INGN 241 is being tested in a Phase 2 clinical trial for patients suffering from advanced melanoma and in a Phase 3 clinical trial in combination with radiation therapy in solid tumors. The mda-7 gene is the active component of INGN 241 and was discovered in the laboratory of Dr. Paul B. Fisher, professor of clinical pathology at Columbia University. Introgen holds an exclusive worldwide sublicense to the Columbia University rights for all gene therapy applications from GlaxoSmithKline.

About Introgen

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale
'"/>




Page: 1 2 3

Related medicine technology :

1. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
2. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
3. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
4. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
5. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
10. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
(Date:7/1/2015)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology company ... announced today that Daniel P. Gold , Ph.D., President ... Fitzgerald Healthcare Conference on Wednesday, July 8, 2015 at 8:30 ... New York . A live webcast of ... replay will be available approximately one hour after the presentation. ...
(Date:7/1/2015)... Lupin , Strides , ... Sub-licensees to Fourteen Companies     ... of its network of generic manufacturers to 14 companies now ... (ARVs). New companies Lupin and Strides Arcolab recently signed agreements ... MPP licensed from ViiV Healthcare two months after its approval ...
(Date:7/1/2015)... , July 1, 2015  AVACEN, Inc. announced today the ... patent covering the medical technology platform supporting its unique Dry ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... methods patent no. 9,066,781 - Methods And Apparatus For Therapeutic ... AVACEN and specific methods of use, referred to by the ...
Breaking Medicine Technology:MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3AVACEN Medical Patent Issued 2
... Accuray Incorporated (Nasdaq: ARAY ), a global leader ... report results for its third quarter of fiscal 2011, ended ... market closes. A conference call to review the ... will be hosted by Euan S. Thomson, Ph.D., president and ...
... YORK, April 14, 2011 Reportlinker.com announces that a ... North America Dental Devices Market ... North America Dental Devices Market Outlook ... GlobalData,s new report, "North America Dental Devices Market Outlook ...
Cached Medicine Technology:Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2011 2Reportlinker Adds North America Dental Devices Market Outlook to 2017 2Reportlinker Adds North America Dental Devices Market Outlook to 2017 3Reportlinker Adds North America Dental Devices Market Outlook to 2017 4Reportlinker Adds North America Dental Devices Market Outlook to 2017 5Reportlinker Adds North America Dental Devices Market Outlook to 2017 6Reportlinker Adds North America Dental Devices Market Outlook to 2017 7Reportlinker Adds North America Dental Devices Market Outlook to 2017 8Reportlinker Adds North America Dental Devices Market Outlook to 2017 9Reportlinker Adds North America Dental Devices Market Outlook to 2017 10Reportlinker Adds North America Dental Devices Market Outlook to 2017 11Reportlinker Adds North America Dental Devices Market Outlook to 2017 12Reportlinker Adds North America Dental Devices Market Outlook to 2017 13
(Date:7/2/2015)... ... 02, 2015 , ... Denver-based SlimGenics Weight Control Centers, the ... No. 14 on ColoradoBiz magazine’s Top 100 Woman-Owned Companies list. ColoradoBiz compiles the ... The award identifies outstanding woman-owned businesses that demonstrate excellence and success in the ...
(Date:7/1/2015)... Angeles, CA (PRWEB) , ... July 01, 2015 , ... ... the great outdoors. Yet, in many Middle-Eastern countries like Saudi Arabia and Dubai, the ... to relax in more temperate climates. Celebrity dentist Dr. Sam Saleh of ORA Dentistry ...
(Date:7/1/2015)... ... ... Sir Fazle Hasan Abed, BRAC’s founder and chairperson, was announced as the ... for his outstanding contribution to enhancing the world's production and distribution of food to ... Prize Foundation, announced this year’s winner at a ceremony at the State Department in ...
(Date:7/1/2015)... Seattle, WA (PRWEB) , ... July 01, 2015 ... ... culture war in this land of liberty. Americans have been arguing over laws ... was a particularly contentious period, as a forthcoming historical comparative biography by Cindy ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... today announced that its fifth annual Smile for a Lifetime Foundation (S4L) fundraising ... non-profit organization. In addition to supporting S4L in its mission to provide free ...
Breaking Medicine News(10 mins):Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3
... ... every 6 men in the United States (1 in 3 in the African American community), ... by registering for Little Red Door,s Unite 2 Fight Race Against Prostate Cancer. , ... Indianapolis, IN (PRWEB) April 13, 2010 ...
... ... Multiple Sclerosis through Community , ... (PRWEB) April 13, 2010 -- Motivational Speaker/MS Advocate and Author Erin Morrow ... with Multiple Sclerosis. , , ,Published by iUniverse with a forward by Harold ...
... social fear and appear open, friendly to all, researchers ... Children with a rare condition called Williams syndrome appear ... a new study shows. , The finding suggests that ... stereotyping. , French and German researchers examined the behaviors ...
... Alzheimer,s patients with dignity and respect, researchers say ... memory loss can still "remember" feelings associated with happy ... University of Iowa researchers showed clips of happy and ... patients couldn,t remember what they had watched, but they ...
... Americans (96 percent of Republicans, 10 percent of Democrats ... care reform legislation that was signed into law by ... national survey conducted April 6 - 10 by researchers ... Research (CHPPR). Americans 18 to 34 years ...
... TCT 2010 (Transcatheter Cardiovascular Therapeutics) will provide ... in interventional cardiology that will directly affect patient ... interventional cardiology has figured prominently in recent current ... received a heart stent in February at New ...
Cached Medicine News:Health News:Registration Now Open for Little Red Door's Unite 2 Fight Race Against Prostate Cancer Saturday, July 10, 2010 2Health News:Author Erin Morrow Still Releases "Fighting MS: Strength in Numbers" 2Health News:Author Erin Morrow Still Releases "Fighting MS: Strength in Numbers" 3Health News:Kids With Rare Condition Lack Racial Prejudice 2Health News:Even As Memory Fades, Emotions Linger 2Health News:Health care reform 'important' even to those who want new law repealed 2Health News:TCT 2010 to have significant impact on interventional cardiology practices and patient care 2
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
... RoamAlert Integrity system builds on the ... door controllers in the system are ... a standard Windows® operating system, which ... of a personal computer, RoamAlert Integrity ...
... Radianse indoor positioning solution ... of where and when ... flow through care processes. ... provides intelligence that hospitals ...
Medicine Products: